Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SICOB Italian clinical practice guidelines for the surgical treatment of obesity and associated diseases using GRADE methodology on bariatric and metabolic surgery.
De Luca M, Zese M, Bandini G, Zappa MA, Bardi U, Carbonelli MG, Carrano FM, Casella G, Chianelli M, Chiappetta S, Iossa A, Martinino A, Micanti F, Navarra G, Piatto G, Raffaelli M, Romano E, Rugolotto S, Serra R, Soricelli E, Vitiello A, Schiavo L, Zani ICM, Ragghianti B, Lorenzoni V, Medea G, Antognozzi V, Bellini R, Berardi G, Campanile FC, Facchiano E, Foletto M, Gentileschi P, Olmi S, Petrelli M, Pilone V, Sarro G, Ballardini D, Bettini D, Costanzi A, Frattini F, Lezoche G, Neri B, Porri D, Rizzi A, Rossini R, Sessa L, D'Alessio R, Di Mauro G, Tolone S, Bernante P, Docimo L, Foschi D, Angrisani L, Basso N, Busetto L, Di Lorenzo N, Disoteo O, Forestieri P, Musella M, Paolini B, Silecchia G, Monami M. De Luca M, et al. Among authors: disoteo o. Updates Surg. 2024 Oct 17. doi: 10.1007/s13304-024-01996-z. Online ahead of print. Updates Surg. 2024. PMID: 39419949
Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment.
Chianelli M, Busetto L, Vettor R, Annibale B, Paoletta A, Papini E, Albanese A, Carabotti M, Casarotto D, De Pergola G, Disoteo OE, Grandone I, Medea G, Nisoli E, Raffaelli M, Schiff S, Vignati F, Cinquini M, Gonzalez-Lorenzo M, Fittipaldo VA, Minozzi S, Monteforte M, Tralongo AC, Novizio R, Persichetti A, Samperi I, Scoppola A, Borretta G, Carruba M, Carbonelli MG, De Luca M, Frontoni S, Corradini SG, Muratori F, Attanasio R. Chianelli M, et al. Among authors: disoteo oe. J Endocrinol Invest. 2024 Jun;47(6):1361-1371. doi: 10.1007/s40618-024-02361-y. Epub 2024 Apr 17. J Endocrinol Invest. 2024. PMID: 38630213
Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program.
Molteni L, Marelli G, Castagna G, Brambilla L, Acerbis M, Alberghina F, Carpani A, Chiavenna E, Ferlini MG, Impellizzeri C, Paredi R, Rigamonti A, Rivolta G, Disoteo OE. Molteni L, et al. Among authors: disoteo oe. Endocr Metab Immune Disord Drug Targets. 2024;24(12):1422-1430. doi: 10.2174/0118715303294909240221102552. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38425116 Free PMC article.
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age.
Lisco G, Disoteo OE, De Tullio A, De Geronimo V, Giagulli VA, Monzani F, Jirillo E, Cozzi R, Guastamacchia E, De Pergola G, Triggiani V. Lisco G, et al. Among authors: disoteo oe. Nutrients. 2023 Dec 25;16(1):63. doi: 10.3390/nu16010063. Nutrients. 2023. PMID: 38201893 Free PMC article. Review.
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide.
Lunati ME, Cimino V, Bernasconi D, Gandolfi A, Morpurgo PS, Tinari C, Lazzaroni E, Baruffaldi L, Muratori M, Montefusco L, Pastore I, Rossi A, Franzetti IG, Muratori F, Manfrini R, Disoteo OE, Terranova R, Desenzani P, Girelli A, Ghelardi R, D'Addio F, Ben Nasr M, Berra C, Folli F, Bucciarelli L, Fiorina P. Lunati ME, et al. Among authors: disoteo oe. Pharmacol Res. 2024 Jan;199:107040. doi: 10.1016/j.phrs.2023.107040. Epub 2023 Dec 20. Pharmacol Res. 2024. PMID: 38128857 Free article.
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes.
Lisco G, De Tullio A, Iovino M, Disoteo O, Guastamacchia E, Giagulli VA, Triggiani V. Lisco G, et al. Among authors: disoteo o. Biomedicines. 2023 Nov 7;11(11):2993. doi: 10.3390/biomedicines11112993. Biomedicines. 2023. PMID: 38001993 Free PMC article. Review.
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care.
Morieri ML, Candido R, Frontoni S, Disoteo O, Solini A, Fadini GP; PIONEERING EXPERIENCE study group. Morieri ML, et al. Among authors: disoteo o. Diabetes Ther. 2023 Dec;14(12):2159-2172. doi: 10.1007/s13300-023-01490-6. Epub 2023 Oct 18. Diabetes Ther. 2023. PMID: 37848758 Free PMC article.
31 results